Related Experiment Video
Updated: Aug 15, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
A rare mutation [IVS-I-130 (G-A)] in a Turkish beta-thalassemia major patient
G O Tadmouri1, O Bilenoğlu, S Kantarci
1Department of Molecular Biology, Boğaziçi University, Bebek, Istanbul, Turkey.
Abstract:
Here we describe the identification of the rare beta-thalassemia mutation IVS-I-130 (G-A) for the first time in Turkey. The hematological evaluation of the patient showed classical signs of beta-thalassemia major requiring regular blood transfusions every 30-35 days. DNA analysis was carried out using reverse dot-blot hybridization and restriction endonuclease digestion, as well as genomic sequencing. The patient was found to be heterozygous for the IVS-I-6 (T-C) and IVS-I-130 (G-A) mutations. In order to deduce a possible origin for the IVS-I-130 (G-A) mutation, the sequence polymorphisms in the DNA of the patient and her family were characterized. The method included the analysis of nine polymorphic nucleotides and the hypervariable microsatellite of composite sequence (AT)(x)T(y) 5' to the beta-globin gene by DNA sequencing. The sequence haplotype (HT4) carrying the IVS-I-130 (G-A) mutation is also observed in Algeria. This favors a Northeastern African origin for this allele. The observed results agree well with a recent introduction of this mutation to Turkey from Egypt toward the end of the 19th century.
Insights
The rare beta-thalassemia mutation IVS-I-130 (G-A) was identified in Turkey. Genetic analysis suggests a Northeastern African origin, likely introduced from Egypt in the late 19th century.
Area of Science:
- Medical Genetics
- Molecular Biology
- Hematology
Background:
- Beta-thalassemia is a significant inherited blood disorder.
- Identifying rare mutations is crucial for understanding disease prevalence and origins.
- The IVS-I-130 (G-A) mutation is a rare cause of beta-thalassemia.
Observation:
- A patient in Turkey presented with classical signs of beta-thalassemia major.
- DNA analysis revealed heterozygosity for IVS-I-6 (T-C) and the novel IVS-I-130 (G-A) mutations.
- Haplotype analysis of the patient and family was performed using DNA sequencing.
Findings:
- The IVS-I-130 (G-A) mutation was identified for the first time in Turkey.
- The genetic haplotype (HT4) associated with the IVS-I-130 (G-A) mutation is also found in Algeria.
- This points to a Northeastern African origin for the IVS-I-130 (G-A) mutation.
Implications:
- The findings suggest a recent introduction of this beta-thalassemia mutation into Turkey from Egypt.
- Understanding mutation origins aids in tracing population genetics and disease spread.
- This research contributes to the genetic mapping of beta-thalassemia in the region.
Related Concept Videos
Mutations
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Mutations
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Point and Frameshift Mutations

